Company: ARTL
Filing Date: 2025-11-17
Form Type: S-1
Source: 0001640334-25-002154
Chunk: 47

Company: ARTELO BIOSCIENCES, INC.
Filing Date: 2025-11-17
Form: S-1
Chunk 47
---
 13(c), 14 or 15(d) of the Exchange Act prior to the termination of this offering, including all such documents we may file with the SEC after the date of the initial registration statement and prior to the effectiveness of the registration statement, but excluding any information furnished to, rather than filed with, the SEC, will also be incorporated by reference into this prospectus and deemed to be part of this prospectus from the date of the filing of such reports and documents.

We will provide you without charge, upon your oral or written request, with a copy of any or all reports, proxy statements and other documents we file with the SEC, as well as any or all of the documents incorporated by reference in this prospectus or the registration statement (other than exhibits to such documents unless such exhibits are specifically incorporated by reference into such documents). Requests for such copies should be directed to Artelo Biosciences, Inc., Attn: Chief Executive Officer, 505 Lomas Santa Fe, Suite 160, Solana Beach, California, 92075. You may also direct any requests for documents to us by telephone at (858) 925-7049.

| 32 |

<div align='center'>Artelo Biosciences, Inc.

Up to 899,972 Shares of Common Stock</div>

| PRELIMINARY PROSPECTUS |

<div align='center'>November 17, 2025</div>

<div align='center'>PART II

INFORMATION NOT REQUIRED IN THE PROSPECTUS</div>

Item 13. Other Expenses of Issuance and Distribution.

The following table sets forth all expenses paid or payable by the registrant in connection with this offering. All amounts shown are estimates except for the SEC registration fee.

|                              |     | Amount Paidor to Be Paid |         |
|:-----------------------------|:----|:-------------------------|--------:|
| SEC registration fee         |     | $                        |     225 |
| Printing expenses            |     |                          |   5,000 |
| Legal fees and expenses      |     | $                        |  75,000 |
| Accounting fees and expenses |     |                          |  25,000 |
| Other fees and expenses      |     |                          |       - |
| Total                        |     | $                        | 105,225 |

Item 14. Indemnification of Directors and Officers.

The Company’s Articles of Incorporation and Bylaws provide that, to the fullest extent permitted by the laws